Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 8/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | BID | P55957 | 3/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.43 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.43 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.43 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.43 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.43 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.43 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.43 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.42 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL28438232 | 0.88 | LTB4R (0.58) | LTB4RALDH1A1GPR35BIDMCL1 | |
| SCHEMBL9093730 | 0.88 | LTB4R (0.51) | LTB4RALDH1A1GPR35HPGDHSD17B10 | |
| SCHEMBL6065211 | 0.86 | EPHX1 (0.44) | LTB4RALDH1A1 | |
| SCHEMBL28904223 | 0.83 | LTB4R (0.44) | LTB4RALDH1A1GPR35HPGDHSD17B10 | |
| SCHEMBL15152496 | 0.81 | LTB4R (0.49) | LTB4RGPR35BIDMCL1BCL2L1 | |
| SCHEMBL15648187 | 0.81 | LTB4R (0.49) | LTB4RGPR35BIDMCL1BCL2L1 | |
| SCHEMBL28854260 | 0.81 | LTB4R (0.49) | LTB4RGPR35BIDMCL1BCL2L1 | |
| SCHEMBL6260351 | 0.81 | LTB4R (0.49) | LTB4RGPR35BIDMCL1BCL2L1 | |
| SCHEMBL14690810 | 0.81 | LTB4R (0.49) | LTB4RGPR35BIDMCL1BCL2L1 | |
| SCHEMBL28037072 | 0.81 | LTB4R (0.49) | LTB4RGPR35BIDMCL1BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060247458-A1 | Process for the production of optically active compounds having substituents at the 2-position | KANEKA CORPORATION (JP) | 2006-11-02 | — | — | US | disclosed |
| EP-1600438-A1 | PROCESSES FOR THE PRODUCTION OF OPTICALLY ACTIVE COMPOUNDS HAVING SUBSTITUENTS AT THE 2-POSITION | KANEKA CORPORATION (JP) | 2005-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247458-A1 | Process for the production of optically active compounds having substituents at the 2-position | TST, TMT1A, OSGEP | LTB4R 1341/4885ALDH1A1 471/4885GPR35 2683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.